ConductScience.org, home

Paper3285482

Steroid receptors and other prognostic factors in primary breast cancer.

Clark GM and 1 other. Semin Oncol, 1988. Cited by 202 papers, by iCite.

Cite this record

ConductScience Library. Steroid receptors and other prognostic factors in primary breast cancer. Papers, record 3285482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3285482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Steroid receptors and other prognostic factors in primary breast cancer.
PubMed
Journal
Semin Oncol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
202
iCite
Relative citation ratio, by iCite
5.66
iCite
Revised in PubMed
2018-05-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark GMG M
2McGuire WLW L

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, SteroidMajor topic
Cell Division
Female
Flow Cytometry
Gene Amplification
Humans
Oncogenes
Ploidies
Prognosis
Thymidine

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA 30195NCI NIH HHSUnited StatesP01CA030195PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.

PMIDTitleJournalYearIn PapersSource
40943316Increased Antiproliferative Activity of Antiestrogens and Neratinib Treatment by Calcitriol in HER2-Positive Breast Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/40943316PubMed
40283001Role of Progesterone Receptor Level in Predicting Axillary Lymph Node Metastasis in Clinical T1-T2N0 Luminal Type Breast Cancer.Medicina (Kaunas)2025https://conductscience.org/library/papers/40283001PubMed
39528903Immunohistochemical-Based Molecular Subtypes of Female Breast Cancer: A Retrospective Cross-Sectional Study at Cheikh Khalifa Hospital in Casablanca, Morocco.Cancer Control2024https://conductscience.org/library/papers/39528903PubMed
38542136EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells.Int J Mol Sci2024https://conductscience.org/library/papers/38542136PubMed
35018235Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells.Am J Cancer Res2021https://conductscience.org/library/papers/35018235PubMed
32754412The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer.Cureus2020https://conductscience.org/library/papers/32754412PubMed
32519274Estrogen Receptor Positive and Progesterone Receptor Negative Breast Cancer: the Role of Hormone Therapy.Horm Cancer2020https://conductscience.org/library/papers/32519274PubMed
31009200Cross-Correlative Single-Cell Analysis Reveals Biological Mechanisms of Nanoparticle Radiosensitization.ACS Nano2019https://conductscience.org/library/papers/31009200PubMed
30572486Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.Medicine (Baltimore)2018https://conductscience.org/library/papers/30572486PubMed
27884978Oestrogen receptor negativity in breast cancer: a cause or consequence?Biosci Rep2016https://conductscience.org/library/papers/27884978PubMed
27698895African American Race is an Independent Risk Factor in Survival from Initially Diagnosed Localized Breast Cancer.J Cancer2016https://conductscience.org/library/papers/27698895PubMed
26998112The correlation between DNMT1 and ERα expression and the methylation status of ERα, and its clinical significance in breast cancer.Oncol Lett2016https://conductscience.org/library/papers/26998112PubMed
26563278ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.Pathol Oncol Res2016https://conductscience.org/library/papers/26563278PubMed
26346768Roles for miRNAs in endocrine resistance in breast cancer.Endocr Relat Cancer2015https://conductscience.org/library/papers/26346768PubMed
25215949Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells.Cell Death Differ2014https://conductscience.org/library/papers/25215949PubMed
24678876Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.BMC Cancer2014https://conductscience.org/library/papers/24678876PubMed
22970719The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?J Environ Sci Health C Environ Carcinog Ecotoxicol Rev2012https://conductscience.org/library/papers/22970719PubMed
22362381The epigenetic silencing of the estrogen receptor (ER) by hypermethylation of the ESR1 promoter is seen predominantly in triple-negative breast cancers in Indian women.Tumour Biol2012https://conductscience.org/library/papers/22362381PubMed
21966546Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance.Transl Oncol2011https://conductscience.org/library/papers/21966546PubMed
21399893Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.Breast Cancer Res Treat2012https://conductscience.org/library/papers/21399893PubMed

See all 55 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3285482

GET https://conductscience.org/api/papers/v1/3285482/cited_by?page=2